Cases & Deals

Celgene defends its leading product Revlimid® against patent revocation actions in UK

Clients Celgene Corporation

Jones Day acted for Celgene Corporation in multiple cases brought by Accord Healthcare in the UK High Court (patents court) in relation to Celgene's patents concerning its best-selling drug, Revlimid®.

Accord Healthcare Limited v. Celgene Corporation, HP 2017 000036, 000038 (UK High Court)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.